Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
284.05
-14.9 (-4.98%)
BSENSE

May 14

BSE+NSE Vol: 20000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 111.74%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 193.86%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 73.14%

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -21.67%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Speciality Medi. With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
58.27
21.32
36.95
173.31%
Other Operating Income
0.00
0.03
-0.03
-100.00%
Total Operating income
58.27
21.35
36.92
172.93%
Raw Material Cost
0.00
15.12
-15.12
-100.00%
Purchase of Finished goods
51.52
0.00
51.52
(Increase) / Decrease In Stocks
-9.34
-0.43
-8.91
-2,072.09%
Employee Cost
2.08
2.73
-0.65
-23.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4.93
6.41
-1.48
-23.09%
Total Expenditure (Excl Depreciation)
49.18
23.83
25.35
106.38%
Operating Profit (PBDIT) excl Other Income
9.09
-2.48
11.57
466.53%
Other Income
0.27
1.62
-1.35
-83.33%
Operating Profit (PBDIT)
9.36
-0.86
10.22
1,188.37%
Interest
0.47
0.01
0.46
4,600.00%
Exceptional Items
0.00
-111.76
111.76
100.00%
Gross Profit (PBDT)
8.89
-0.87
9.76
1,121.84%
Depreciation
0.20
2.08
-1.88
-90.38%
Profit Before Tax
8.69
-2.96
11.65
393.58%
Tax
0.08
-1.03
1.11
107.77%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
8.61
-1.92
10.53
548.44%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
-111.76
111.76
100.00%
Net Profit
8.61
-113.68
122.29
107.57%
Equity Capital
6.44
22.43
-15.99
-71.29%
Face Value
10.00
1.00
0.00
Reserves
23.98
933.69
-909.71
-97.43%
Earnings per share (EPS)
13.37
-5.07
18.44
363.71%
Diluted Earnings per share
14.10
-5.07
19.17
378.11%
Operating Profit Margin (Excl OI)
15.60%
-11.63%
0.00
27.23%
Gross Profit Margin
15.26%
-4.08%
0.00
19.34%
PAT Margin
14.78%
-9.01%
0.00
23.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 58.27 Cr
in Mar 2025

Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 8.61 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.09 Cr
in Mar 2025

Figures in Cr
Annual - Interest
Interest 0.47 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.60%
in Mar 2025

Figures in %